Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs

被引:18
|
作者
Chapman, RW [1 ]
House, A [1 ]
Liu, F [1 ]
Celly, C [1 ]
Mei, H [1 ]
Hey, JA [1 ]
机构
[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA
关键词
cough; tachykinin NK1 receptor; CP-99994; (dog);
D O I
10.1016/j.ejphar.2003.11.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CP-99994 [(+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine] is a selective tachykinin NK1 receptor antagonist that inhibits cough in guinea pigs and cats. This study examined the antitussive effects of CP-99994 in dogs produced by mechanical stimulation of the intrathoracic trachea. CP-99994 (10 mg/kg, p.o.) inhibited cough frequency by 52% at 2 h, 31% at 6 h and by 21% at 24 h. Cough amplitude was inhibited by 45% at 6 h but unchanged at 2 and 24 h after CP-99994. Plasma levels of CP-99994 were highest at 2 h (75 +/- 26 ng/ml) and fell to 22 +/- 6 ng/ml at 6 h. These results demonstrate antitussive activity of CP-99994 in dogs at a dose proven to antagonize tachykinin NK1 receptors in this species. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 50 条
  • [1] Opioid activity of sendide, a tachykinin NK1 receptor antagonist
    Sakurada, T
    Yuhki, M
    Inoue, M
    Sakurada, C
    Koichi, TN
    Ohba, M
    Kisara, K
    Sakurada, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 369 (03) : 261 - 266
  • [2] ANTINOCICEPTIVE ACTIVITY OF THE TACHYKININ NK1 RECEPTOR ANTAGONIST, CP-99,994, IN CONSCIOUS GERBILS
    RUPNIAK, NMJ
    WEBB, JK
    WILLIAMS, AR
    CARLSON, E
    BOYCE, S
    HILL, RG
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) : 1937 - 1943
  • [3] PHARMACOLOGY OF CP-99,994 - A NONPEPTIDE ANTAGONIST OF THE TACHYKININ NK1 RECEPTOR
    MCLEAN, S
    GANONG, A
    SEYMOUR, PA
    SNIDER, RM
    DESAI, MC
    ROSEN, T
    BRYCE, DK
    LONGO, KP
    REYNOLDS, LS
    ROBINSON, G
    SCHMIDT, AW
    SIOK, C
    HEYM, J
    REGULATORY PEPTIDES, 1992, : S120 - S120
  • [4] MEN 11149, a potent antagonist of the tachykinin NK1 receptor
    Astolfi, M
    Parlani, M
    Lopez, G
    Conte, B
    Cirillo, R
    Fincham, CI
    Terracciano, R
    Manzini, S
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P202 - P202
  • [5] A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity
    Zachrisson, O
    Lindefors, N
    Brené, S
    MOLECULAR BRAIN RESEARCH, 1998, 60 (02): : 291 - 295
  • [6] Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat
    Bolser, DC
    DeGennaro, FC
    OReilly, S
    McLeod, RL
    Hey, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) : 165 - 170
  • [7] Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist
    Cascieri, MA
    Ber, E
    Fong, TM
    Hale, JJ
    Tang, F
    Shiao, LL
    Mills, SG
    MacCoss, M
    Sadowski, S
    Tota, MR
    Strader, CD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (2-3) : 253 - 261
  • [8] Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets
    Gonsalves, S
    Watson, J
    Ashton, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 305 (1-3) : 181 - 185
  • [9] NK-1A AND NK-1B SUBTYPES DISTINGUISHED BY CP-99994 AND SEPTIDE COMPETITION IN PORCINE TRACHEA
    YOHANNAN, MD
    MARTIN, RJ
    ERNSBERGER, P
    FASEB JOURNAL, 1995, 9 (04): : A684 - A684
  • [10] CYCLOSPORINE-A IS A SUBSTANCE-P (TACHYKININ NK1) RECEPTOR ANTAGONIST
    GITTER, BD
    WATERS, DC
    THRELKELD, PG
    LOVELACE, AM
    MATSUMOTO, K
    BRUNS, RF
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (03): : 439 - 446